{"filings":[{"id":1894807,"accession_number":"0000950103-26-011218","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-07-27T22:01:40+00:00","items":["1.02","2.01","3.01","3.03","5.01","5.02","5.03","8.01","9.01"],"status":"ready","headline":"Knox Lane completes acquisition of Cross Country Healthcare for $13.25/share; Joel Tremblay named CEO","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Merger closed July 21, 2026; shareholders received $13.25 per share in cash.","Joel Tremblay appointed CEO; Kevin Clark retires as CEO and Chairman.","Company becomes privately held; common stock delisted from Nasdaq.","Locums division acquired by All Star Healthcare Solutions, a Knox Lane portfolio company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1701476,"accession_number":"0000950103-26-010760","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-07-17T12:19:25+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cross Country Healthcare stockholders approve merger to go private; expected Q3 2026 close","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Proposal to adopt merger agreement approved: 23,356,105 for, 12,309 against, 10,439 abstentions.","Advisory compensation proposal approved: 20,281,587 for, 1,855,191 against, 1,242,075 abstentions.","Merger with KL Criss Cross Intermediate expected to close in Q3 2026, subject to conditions.","Upon closing, company will no longer be publicly held; common stock to be delisted from NASDAQ."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1453077,"accession_number":"0000950103-26-010220","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-07-06T10:17:20+00:00","items":["8.01"],"status":"ready","headline":"Cross Country Healthcare sets July 16 special meeting; supplements proxy after merger lawsuits","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Special meeting to approve merger with KL Criss Cross Intermediate set for July 16, 2026; record date June 12.","Two lawsuits filed (Malone and Walsh) alleging proxy statement deficiencies; company denies merit but voluntarily supplements.","Supplemental disclosures include BofA Securities financial analysis details and post-closing consulting discussions with executives.","Company expects merger to close in Q3 2026 subject to stockholder approval and other conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1204800,"accession_number":"0000950103-26-009315","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-06-23T12:30:25+00:00","items":["8.01","9.01"],"status":"ready","headline":"HSR waiting period expires for Cross Country Healthcare merger; shareholder vote set for July 16, 2026","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["HSR Act waiting period for the merger and Locums Transaction expired June 22, 2026, satisfying a major condition.","Merger expected to close in Q3 2026, subject to other customary closing conditions.","Special shareholder meeting to approve the merger is scheduled for July 16, 2026 at 12:00 p.m. ET.","Cross Country will be acquired by KL Criss Cross Intermediate, LLC and survive as a wholly-owned subsidiary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91539,"accession_number":"0001628280-26-032217","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q1 2026 revenue down 18% YoY, net loss widens to $4.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $241.1M, down 18% YoY; gross profit margin 19.7%, down 30 bps.","Net loss attributable to common stockholders $4.3M vs $0.5M loss in Q1 2025.","Diluted EPS loss $0.14; adjusted EPS loss $0.03.","Adjusted EBITDA $3.9M, down 55% YoY; adjusted EBITDA margin 1.6%.","Cash flow from operations $4.8M, down 16% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":241057000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91538,"accession_number":"0000950103-26-006921","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to be acquired by Knox Lane for $13.25/share in $437M all-cash deal","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Deal valued at ~$437M, with stockholders receiving $13.25 per share in cash.","31% premium to May 6 closing price and 45% premium to 90-day VWAP.","Expected to close Q3 2026, subject to stockholder approval and HSR clearance.","Company cancels Q1 2026 earnings call (May 7) and 2026 Annual Meeting (May 11).","Equity financing from Knox Lane secured; termination fee of ~$14.2M applies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91537,"accession_number":"0001628280-26-025765","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-04-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare schedules Q1 2026 earnings call for May 7","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Earnings call on May 7, 2026 at 5:00 PM ET after market close.","Results will be released after market close on the same day.","Dial-in: US 800-369-2163 or Intl 773-756-4715, passcode: Cross Country.","Webcast accessible at ir.crosscountry.com; replay through May 21."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101693,"accession_number":"0000929638-26-001241","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cross Country Healthcare appoints Amiee Hawkins as COO effective March 28","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Hawkins, previously Chief Solutions & Operations Officer, promoted to COO.","She joined the company in 2014 and held multiple VP and SVP roles.","No change to her compensation or new agreement was made in connection with the appointment.","No family relationships with directors or executive officers; no arrangement with any person.","Board approved the appointment on March 25, 2026, effective March 28, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101692,"accession_number":"0000929638-26-001038","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cross Country Healthcare CIO Phil Noe departs; receives $205,975 severance, consulting role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Phil Noe ceased as Chief Information Officer effective March 10, 2026.","Noe will receive $205,975 severance (six months salary) under Separation Agreement.","Noe entered into Consulting Agreement from March 11 to May 31, 2026 at $198.04/hour.","Noe will provide consulting on technology, telephones, and related infrastructure.","No replacement for CIO role announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101691,"accession_number":"0000929638-26-000955","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cross Country Healthcare appoints Marvin Veizaga as CAO; James Redd and Phil Noe depart","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["James V. Redd III ceases as SVP & Chief Accounting Officer effective March 10, 2026; no dispute with company.","Phil Noe ceases as Chief Information Officer effective March 10, 2026; departure not due to disagreement.","Marvin Veizaga, previously Group VP Corporate Controller, appointed SVP & CAO, reporting to CFO.","Veizaga receives base salary increase to $340,000; STI and LTI targets each at 50% of base salary.","No family relationships or material interest in transactions for new CAO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101690,"accession_number":"0001628280-26-014650","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q4 2025 revenue down 24% YoY; net loss of $82.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $236.8M in Q4 2025, down 24% YoY; full-year revenue $1.054B, down 22%.","Net loss attributable to common $82.9M in Q4 versus $3.8M loss a year ago; diluted EPS $(2.56).","Adjusted EBITDA $4.1M in Q4, margin 1.7% (down 130bps YoY); full-year adjusted EBITDA $26.8M.","Cash from operations $18.2M in Q4; full year $48.3M, down 60% YoY.","Adjusted EPS was $(0.06) in Q4 vs $0.04 in prior-year quarter; full-year adjusted EPS $0.02."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101689,"accession_number":"0001628280-26-010662","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to attend two investor conferences in March 2026","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Truist Securities Virtual Human Capital Conference March 12-13, one-on-one March 12.","Oppenheimer Healthcare MedTech & Services Conference March 16-19, one-on-one March 17.","CFO William J. Burns and VP IR Josh Vogel to attend both conferences.","No formal presentation will be made at either event."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101688,"accession_number":"0001628280-26-007704","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare schedules Q4/FY 2025 earnings call for March 4, 2026","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Earnings call on Wednesday, March 4, 2026 at 5:00 PM ET.","Press release with financial results to be issued after market close on March 4.","Dial-in: 800-369-2163 (U.S.) or 773-756-4715 (non-U.S.); passcode: Cross Country.","Webcast available at ir.crosscountry.com; replay through March 18."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101687,"accession_number":"0001628280-26-004147","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["5.08","8.01"],"status":"ready","headline":"Cross Country Healthcare sets 2026 annual meeting for May 11, updates proposal deadlines","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["2026 annual meeting will be held virtually on May 11, 2026.","Stockholder proposals under Rule 14a-8 must be received by March 11, 2026.","Advance notice for nominations or other business due by February 10, 2026.","Universal proxy rule notices required by March 12, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101686,"accession_number":"0001628280-26-000149","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K/A","filed_at":"2026-01-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cross Country Healthcare discloses CEO Kevin Clark's employment terms: $950K salary, bonus, equity","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary $950K; 2026 target bonus 100% of base (max 180%), rising to 125% target from 2027.","Long-term equity: 275% of base for 2025, 300% for 2026, 325% for 2027 and 2028.","Severance on termination without cause/good reason: 24 months base salary plus 2x average bonus, plus COBRA.","Initial 3-year term through Dec 14, 2028, with automatic one-year renewals unless 90-day non-renewal notice.","Non-compete and non-solicitation covenants apply for 2 years post-employment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118018,"accession_number":"0001628280-25-056873","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-12-15T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Cross Country CEO Martins departs; co-founder Clark returns as CEO after Aya deal termination","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO John Martins separated effective Dec 14, 2025; receives severance of 2-year base salary ($875K) plus average bonus.","Chairman and co-founder Kevin Clark appointed President and CEO; will continue as Chairman.","Transition follows termination of transaction with Aya Healthcare; Board believes it's the right time for change.","Clark previously led Cross Country as CEO from 2019 to 2022, a period of rapid growth and strong financial results.","Company plans to sharpen focus, reduce costs, optimize capital allocation for sustainable profitable growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118017,"accession_number":"0001628280-25-056541","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-12-11T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cross Country Healthcare elects 7 directors, ratifies Deloitte, approves say-on-pay at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 7 director nominees elected with strong support; Gale Fitzgerald received the most against votes at 2,651,031.","Ratification of Deloitte & Touche as independent auditor for FY2025 approved with 25,759,187 for, 48,300 against.","Advisory vote on executive compensation approved with 21,724,841 for, 279,383 against.","Broker non-votes existed 3,660,974 on director election and say-on-pay items."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118016,"accession_number":"0000950103-25-015716","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["1.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare merger with Aya Healthcare terminated; to receive $20M fee; starts buybacks","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Merger agreement with Aya Healthcare terminated effective Dec 4, 2025 after failing to close by Dec 3, 2025 end date.","Aya to pay Cross Country a $20 million termination fee within two business days.","Termination due to FTC review not completed; HSR waiting period extended to Dec 30, 2025 because of 43-day government shutdown.","Company to immediately commence share repurchases under existing $40 million authorization.","Company reports no debt and strong cash position; refocuses on standalone strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118015,"accession_number":"0001628280-25-051671","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q3 revenue $250M, down 21% YoY; net loss $4.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $250.1M, down 21% YoY and 9% sequentially; gross margin 20.4% flat.","Net loss $4.8M vs $1.2M in Q3 2024; diluted EPS ($0.15) vs ($0.23) prior year.","Adjusted EBITDA $6.5M, down 37% YoY; adjusted EPS $0.03 vs ($0.09) a year ago.","Cash from operations $20.1M, up 169% YoY and 377% sequentially."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":817532000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134474,"accession_number":"0001628280-25-043262","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-09-30T23:59:59+00:00","items":["5.08","8.01"],"status":"ready","headline":"Cross Country Healthcare sets annual meeting for Dec 9, conditional on Aya merger not closing first","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual Meeting scheduled for virtual-only on December 9, 2025; proxy statement available on or before Oct 30.","Meeting will only occur if Aya merger is not completed before Dec 9; if closed, company becomes Aya subsidiary and meeting cancelled.","Stockholder proposals for Rule 14a-8 inclusion must be received by Oct 10, 2025.","Director nominations and universal proxy notices also due Oct 10, 2025.","Company still expects Aya merger to close in Q4 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134473,"accession_number":"0000950103-25-011190","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-09-03T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Cross Country Healthcare extends merger deadline to Dec 3, 2025; FTC compliance certified","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Merger end date automatically extended from Sept 3, 2025 to Dec 3, 2025 per the Merger Agreement.","Cross Country and Aya have each certified substantial compliance with FTC's Second Request as of Aug 29, 2025.","Merger expected to close in Q4 2025, subject to regulatory approvals and customary conditions.","Terms of the Merger Agreement remain unchanged; other than the End Date extension."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134472,"accession_number":"0001628280-25-038369","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q2 revenue down 19% YoY, net loss of $6.7M, negative adjusted EPS","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $274.1M, down 19% YoY; gross margin 20.4%, down 40 bps.","Net loss attributable to common stockholders $6.7M ($0.20 diluted EPS loss); vs Q2 2024 EPS of $0.27 income.","Adjusted EBITDA $7.6M (2.8% margin), down 46% YoY.","Adjusted EPS loss of $0.01, improved from $0.11 loss in Q2 2024.","Cash from operations $4.2M, down 95% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":567480000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151317,"accession_number":"0001628280-25-023205","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Q1 revenue down 23% YoY to $293.4M; adjusted EPS $0.06","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $293.4M, down 23% YoY; net loss $490K ($0.02 loss per share).","Adjusted EBITDA $8.6M (2.9% margin); adjusted EPS $0.06, improving from $(0.13) YoY.","Gross profit margin 20.0%, down 40bps YoY.","Operating cash flow $5.7M, down 5% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":293408000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170202,"accession_number":"0001628280-25-010495","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare reports Q4 2024 revenue down 25% YoY, net loss of $3.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $309.9M, down 25% YoY and 2% sequentially.","Q4 net loss $3.8M ($0.12 diluted EPS); full year net loss $14.6M.","Adjusted EBITDA $9.3M (-55% YoY); adjusted EPS $0.04.","Full year 2024 revenue $1.34B, down 33% from 2023.","Operating cash flow Q4 $24.2M, up 101% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170201,"accession_number":"0000950103-25-002748","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Stockholders approve Aya Healthcare acquisition; merger expected H2 2025","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Over 78% of shares voted; 25.66M votes for Merger Agreement, 11K against.","Advisory merger-related compensation proposal also approved with 24.3M votes for.","Merger expected to close in second half of 2025, subject to customary conditions.","Upon close, Cross Country becomes private; CCRN common stock to be delisted from NASDAQ."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170200,"accession_number":"0000950103-25-002303","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Cross Country Healthcare receives FTC Second Request for Aya merger; close expected H2 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FTC issued Second Request under HSR Act, extending waiting period until 30 days after substantial compliance by both parties.","Merger close now expected in second half of 2025, delayed from previous timeline.","Company and Aya are working cooperatively with FTC; continue to respond to request.","Merger still requires stockholder approval and other customary closing conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187213,"accession_number":"0000950103-24-017244","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-12-04T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Aya Healthcare to acquire Cross Country Healthcare for $18.61/share (~$615M all-cash)","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Stockholders receive $18.61 per share in cash, a 67% premium to Dec 3 closing price.","Transaction valued at approximately $615 million; no financing condition.","Closing subject to Cross Country stockholder approval and expiration of HSR waiting period.","Termination fee of $20 million payable by either party under specified conditions.","Combined company to expand workforce solutions across healthcare and non-clinical settings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187212,"accession_number":"0001628280-24-045750","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-11-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q3 revenue down 29% YoY to $315M; EPS $0.08","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $315.1M fell 29% YoY; gross margin 20.4%, down 160 bps.","Net income of $2.6M ($0.08 diluted EPS) vs net loss of $0.28 in Q3 2023.","Adjusted EBITDA $10.3M, down 62% YoY; adjusted EPS $0.12 vs $(0.27).","Revenue down 7% sequentially; net income up 116% QoQ.","Operating cash flow $7.5M, down 89% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":1034064000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187211,"accession_number":"0001628280-24-043631","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-10-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to attend UBS Global Healthcare Conference in November 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Participation in UBS Global Healthcare Conference Nov 11-14 at Terranea Resort, CA.","CEO John Martins and VP IR Josh Vogel hold one-on-one meetings on Nov 13.","No formal presentation will be made."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187210,"accession_number":"0001628280-24-043116","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-10-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare schedules Q3 2024 earnings call for Nov 6, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Earnings call on Wednesday, November 6, 2024 at 5:00 p.m. ET.","Earnings press release expected after market close on November 6.","Webcast available at ir.crosscountry.com; dial-in: 888-566-1290 (U.S.) or 773-799-3776 (international).","Telephone replay available from Nov 6 through Nov 20: 800-835-4610 (U.S.), passcode 4915."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203724,"accession_number":"0001628280-24-038030","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-08-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to attend two investor conferences in September 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Morgan Stanley 22nd Annual Global Healthcare Conference: Sept 4-6, NYC; John Martins and Josh Vogel on Sept 5.","17th Annual Barrington Research Virtual Fall Investment Conference: Sept 12; William Burns and Josh Vogel.","One-on-one meetings only; no formal presentations at either conference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203723,"accession_number":"0001628280-24-033758","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Q2 revenue down 37% YoY to $339.8M; net loss of $16.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $339.8M, down 37% YoY and 10% sequentially; gross margin 20.8% (-200 bps YoY).","Net loss attributable to common $16.0M vs net income in Q2 2023; diluted EPS ($0.47).","Adjusted EBITDA $14.2M, margin 4.2% (-400 bps YoY); adjusted EPS $0.10 vs ($0.59) a year ago.","Cash from operations $82.4M, up 1,271% sequentially; no guidance update provided."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.39,"consensus_revenue_estimate":null,"consensus_revenue_actual":718945000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203722,"accession_number":"0001628280-24-033300","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-07-29T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Cross Country Healthcare amends ABL credit agreement to ease share repurchase restrictions","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 7 to ABL Credit Agreement with Wells Fargo, dated July 29, 2024, relaxes share repurchase covenant.","Share repurchases before June 30, 2024 and future repurchases allowed if no revolving ABL loans outstanding (excluding interest/fees).","Repurchases excluded from fixed charge coverage ratio calculation, giving more capital-return flexibility.","No default or event of default exists as of amendment effective date; representations and warranties reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203721,"accession_number":"0001628280-24-031698","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-07-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare sets Q2 2024 earnings call for July 31","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Conference call to discuss Q2 2024 results at 5:00 p.m. ET on July 31, 2024.","Earnings press release to be distributed after market close on July 31.","Webcast available at ir.crosscountry.com; dial-in: 888-566-1290 (U.S.) passcode 'Cross Country'.","No financial results included in this filing; call date and logistics only.","Replay available through August 14 via telephone (866-360-8701) and website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220280,"accession_number":"0001628280-24-024957","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-05-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to participate in Citizens JMP conference on June 20, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CEO John Martins and VP IR Josh Vogel will hold one-on-one investor meetings at the Boston Harbor Hotel.","No formal presentation is scheduled.","Company is attending the Citizens JMP Medical Devices and Healthcare Services Forum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220279,"accession_number":"0001628280-24-023746","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-05-16T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Stockholders approve 2024 Omnibus Incentive Plan adding 2.4M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan replaces 2020 Omnibus Incentive Plan; 2,400,000 new shares authorized for equity awards.","Eligible participants include employees, directors, consultants, and key advisors.","Awards may include stock options, stock appreciation rights, stock awards, and cash awards.","Plan expires May 13, 2034; no awards may be granted after that date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220278,"accession_number":"0001628280-24-023426","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-05-15T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cross Country Healthcare shareholders elect all directors, approve auditor, say-on-pay, and 2024 incentive plan","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected with majority votes; Gale Fitzgerald received ~25.1M for vs ~4.5M against.","Ratification of Deloitte & Touche as auditor for FY2024 approved with 31.1M votes for (95.7% of cast).","Advisory vote on executive compensation approved with 28.2M for (95.3% of votes cast).","2024 Omnibus Incentive Plan approved with 27.7M for (93.7% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220277,"accession_number":"0001628280-24-022910","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to attend William Blair and Jefferies healthcare conferences in June 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["William Blair Growth Stock Conference: June 4-6 in Chicago; CEO John Martins and IR Josh Vogel attending.","Jefferies Global Healthcare Conference: June 5-6 in NYC; CFO William Burns and IR Josh Vogel attending.","Formal presentation at William Blair on June 4 at 11:20 a.m. CT; fireside chat at Jefferies on June 6 at 11:30 a.m. ET.","Webcasts available on ir.crosscountry.com under Events and Presentations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220276,"accession_number":"0001628280-24-022199","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Cross Country Healthcare customer files Chapter 11; expects $20M bad debt charge in Q2 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Customer filed Chapter 11 bankruptcy on May 6, 2024.","Cross Country owed approximately $20 million net of reserves and subcontractor receivables.","Company expects to record a bad debt charge in Q2 2024; amount not yet determined.","Customer had been making timely payments under a payment plan prior to filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220275,"accession_number":"0001628280-24-020321","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-05-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to attend Benchmark's Healthcare House Call Investor Conference","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Conference: Benchmark's Healthcare House Call Virtual One-on-One, May 21-22, 2024.","CFO William J. Burns and VP IR Josh Vogel will participate in virtual one-on-one meetings on May 22.","No formal presentation will be made."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220274,"accession_number":"0001628280-24-019637","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q1 revenue down 39% YoY to $379M; net income falls 91%","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Revenue $379.2M, down 39% YoY and 8% sequentially.","Net income $2.7M, down 91% YoY; diluted EPS $0.08 vs -$0.73 in Q1 2023.","Adjusted EBITDA $15.3M (margin 4.0%), down 71% YoY; adjusted EPS $0.19.","Cash from operations $6.0M, down 87% YoY.","Gross margin 20.4%, down 200 bps YoY and 150 bps sequentially."],"consensus_eps_estimate":null,"consensus_eps_actual":0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":379174000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220273,"accession_number":"0001628280-24-015625","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-04-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare announces Q1 2024 earnings call date: May 1, 2024","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Conference call to discuss Q1 2024 results on Wednesday, May 1, 2024 at 5:00 PM ET.","Earnings press release expected after market close on May 1, 2024.","Webcast available at ir.crosscountry.com or by dialing 888-566-1290 (US).","Replay available through May 15, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239954,"accession_number":"0001628280-24-006605","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-02-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to attend Oppenheimer healthcare conference on March 12, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["William J. Burns (CFO) and Josh Vogel (VP IR) will hold virtual one-on-one investor meetings.","No formal presentation will be made at the Oppenheimer 34th Annual Healthcare Conference.","The conference takes place March 12-13, 2024; participation is on March 12 only."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239953,"accession_number":"0001628280-24-005925","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-02-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cross Country Healthcare CCO Daniel J. White to depart March 31, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chief Commercial Officer Daniel J. White will leave the company on March 31, 2024 under a separation agreement.","Agreement provides for continued base salary payments for six months following his departure.","No successor or interim appointment has been disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239952,"accession_number":"0001628280-24-005913","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-02-21T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q4 net income drops 77% on 34% revenue decline","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 revenue $414M, down 34% YoY and 6% sequentially; full year revenue $2.02B, down 28%.","Q4 net income $9.0M (-77% YoY); diluted EPS $0.26 vs $1.05 in Q4 2022.","Q4 adjusted EBITDA $20.6M (-64% YoY); margin 5.0%, down 410 bps YoY.","Q4 cash from ops $12.1M (+179% YoY); full year cash from ops $248.5M (+85% YoY).","Full year adjusted EPS $2.23 vs $5.27 in 2022; net income $72.6M (-61% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":2019728000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239951,"accession_number":"0001628280-24-002913","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2024-02-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare sets Q4 2023 earnings call for Feb 21 after market close","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Earnings release and conference call scheduled for Wednesday, February 21, 2024 at 5:00 p.m. ET.","Results will be distributed after market close on February 21.","Call accessible via webcast at ir.crosscountry.com or by dialing 888-566-1290 (U.S.) or 773-799-3776 (international), passcode: Cross Country.","Telephone replay available through March 6 at 800-391-9851 (U.S.) or 203-369-3268, passcode: 4335."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257477,"accession_number":"0001157523-23-001599","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2023-11-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q3 revenue $442M (-30% YoY), net income $12.8M (-63%), EPS $0.36 vs loss $0.57","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $442.3M, down 30% from Q3 2022 and 18% from Q2 2023.","Net income $12.8M, down 63% YoY and 40% sequentially.","Diluted EPS of $0.36, compared to a loss of $0.57 in Q3 2022.","Adjusted EBITDA $27.2M (6.2% margin), down 57% YoY and 380 bps margin contraction.","Operating cash flow $70.3M, down 50% from Q3 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":1.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":1605693000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257476,"accession_number":"0001157523-23-001471","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2023-10-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare announces Q3 2023 earnings call date; no results disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Earnings call scheduled for November 1, 2023 at 5:00 p.m. ET.","Press release with Q3 results to be issued after market close on November 1.","No financial data provided in this filing; call is purely procedural."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257475,"accession_number":"0001157523-23-001455","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2023-10-02T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Cross Country's ABL covenant becomes springing, tied to excess availability thresholds","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 6 changes fixed charge coverage ratio from maintenance to springing covenant triggered when excess availability falls below greater of 15% of loan cap or $24M.","Once a Compliance Period starts, covenant tested quarterly until excess availability exceeds that threshold for 30 consecutive days.","Cure right added: cash equity contributions can boost consolidated EBITDA within 10 business days of Compliance Period start.","Amendment effective September 29, 2023; all conditions satisfied; existing credit agreement otherwise unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274818,"accession_number":"0001157523-23-001328","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2023-08-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to attend Barrington Research conference; no formal presentation","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["CFO William Burns and VP Josh Vogel will hold one-on-one meetings at the conference on September 14, 2023.","No formal presentation will be made at the 16th Annual Barrington Research Virtual Fall Investment Conference.","Press release issued August 14, 2023; no financial or operational updates provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":423072854.8986228,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-08-14T23:59:59+00:00|274818"}